Document Detail


The role of intrarenal prostaglandins and angiotensin II in acute cyclosporine-induced vasoconstriction.
MedLine Citation:
PMID:  1858042     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cyclosporine causes intrarenal vasoconstriction, which may account for its nephrotoxic effects. In this study we investigated the role of endogenous prostaglandins and angiotensin II in cyclosporine-induced intrarenal vasoconstriction. Split hydronephrotic kidneys in decerebrate rats (n = 16) were suspended in an environmentally controlled tissue bath. Interlobular, afferent, and efferent arteriolar diameters and red blood cell velocity were measured by in vivo video-microscopy and Doppler velocimetry. After topical application of cyclosporine to the kidney in the tissue bath, a 12% +/- 2% constriction of the interlobular and a 28% +/- 5% reduction in interlobular blood flow occurred. The afferent and efferent arterioles also constricted by 13% +/- 2% and 10% +/- 3%, respectively. Prostaglandin inhibition with mefenemate augmented this vasoconstriction (16% +/- 2% at interlobular and 21% +/- 4% at afferent arterioles) and reduction in interlobular blood flow (38% +/- 8%) below baseline values. Mefenemate alone resulted in a 35% +/- 5% reduction in interlobular blood flow, which was not further augmented by cyclosporine. In contrast, local competitive angiotensin II-receptor inhibition with saralasin maintained blood flow after cyclosporine and prevented intrarenal vasoconstriction by cyclosporine. This suggests that prostaglandins protect against intrarenal vasoconstriction and that acute cyclosporine-induced vasoconstriction is mediated through angiotensin II receptors.
Authors:
J S Abraham; F R Bentley; R N Garrison
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Surgery     Volume:  110     ISSN:  0039-6060     ISO Abbreviation:  Surgery     Publication Date:  1991 Aug 
Date Detail:
Created Date:  1991-08-28     Completed Date:  1991-08-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  343-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, University of Louisville School of Medicine, KY 40292.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Sarcosine-8-Isoleucine Angiotensin II / pharmacology
Angiotensin II / physiology*
Animals
Blood Flow Velocity / drug effects
Cyclosporins / pharmacology*
Hemodynamics / drug effects
Kidney / blood supply*
Male
Mefenamic Acid / pharmacology
Microcirculation / drug effects
Prostaglandins / physiology*
Rats
Rats, Inbred Strains
Receptors, Angiotensin / drug effects
Time Factors
Vasoconstriction / drug effects*
Chemical
Reg. No./Substance:
0/Cyclosporins; 0/Prostaglandins; 0/Receptors, Angiotensin; 11128-99-7/Angiotensin II; 61-68-7/Mefenamic Acid; 9088-01-1/1-Sarcosine-8-Isoleucine Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism.
Next Document:  Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock.